Techniques for preparing large populations of anucleate cytoplasms from cultured eukaryotic cells have only recently been described. The principal value of anucleate cytoplasms derives from studies that can be done after they are fused to whole cells. Since present methods for the isolation of heterokaryons are unsuitable for the selection of hybrids between whole cells and anucleate cytoplasms (heteroplasmons), a selective system has been developed which is based on the capacity of anucleate cytoplasms containing active enzymes to rescue whole cells poisoned with iodoacetate. Ethidium bromide, a partially effective agent, was used in conjunction with iodoacetate to demonstrate the feasibility of selecting heterokaryons by producing complementary biochemical lesions in the parental cell strains. The potential for artifact in these systems is not, however, entirely precluded.
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The formation of hybrid cells by virus fusion has been a powerful tool for the study of mechanisms controlling phenotypic expression and metabolic regulation in eukaryotic cells. The classic method for the selection of heterokaryons is that of Littlefield (1) , in which parental cell populations lacking different enzymes (e.g., hypoxanthine phosphoribosyltransferase-and thymidine kinase-) are fused and then planted in a selective medium requiring both enzymes for growth (e.g., hypoxanthine/amethopterin/thymidine medium). This procedure has drawbacks, including (i) restriction to the use of cell types that have (or can be induced to have) appropriate enzyme deficiencies, (ii) the considerable time lag occurring between fusion and selection of a pure population of hybrid cells, and (iii) dependence on the use of heritable traits. This final drawback is of increasing importance in light of the recent development of techniques permitting the production of mass populations of anucleate cytoplasms (2) (3) (4) 9) . The fusion of anucleate cytoplasms, henceforth called "cytoplasts," to whole cells should prove useful in elucidating nucleocytoplasmic interactions, and many such experiments will require the selective isolation of cytoplasmic hybrids.
Since a cytoplast cannot contribute the genetic material necessary to correct a heritable defect in its fusion partner, the classic selective systems are unsuitable. The present study was undertaken in order to develop a selective system that would permit the isolation of cytoplasmic hybrids between whole cells and cytoplasts. We suggest the term "heteroplasmons" to distinguish cytoplasmic hybrids from whole cell hybrids (heterokaryons).
MATERIALS AND METHODS
Cells and Media. The normal human diploid fibroblast cell strain WI-38, derived from fetal lung (5) , was used at population doubling levels between 18 and 26. The growth medium consisted of Eagle's basal medium (6) supplemented with 10% calf serum and 50 Ag/ml of chlortetracycline and buffered to pH 7.4 with 28 MM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer. Because of the difficulty in maintaining sterility throughout the enucleation procedures, the medium was supplemented with 500 units/ml of penicillin, 0.2 mg/ml of streptomycin, and 2,5,ug/ml of amphotericin B for the 3 days after enucleation. In order to provide a richer medium for growth after the trauma of fusion and hybrid selection, the cells were cultured for the next five population doublings in Eagle's basal medium -containing 50% conditioned medium, 20% fetal calf serum, 50 Mg/ml of gentamycin, and twice the normal amount of Eagle's vitamins, amino acids, and glutamine. After this, the cultures were returned to the standard growth medium.
Enucleation. Cells were enucleated by a described method (3). Briefly, cells were grown on the inner surface of 2 inch (5.1 cm) long glass cylinders. These were transferred aseptically to 1 inch (2.5 cm) diameter centrifuge tubes fitted at the bottom with plastic hemispheres which provided a flat surface upon which the cylinders rested. The tubes were filled with medium containing 4 
RESULTS
The fundamental approach in the development of a cytoplasm-dependent selective system was to irreversibly inactivate a vital component(s) of the whole cell, then to rescue that cell by fusing it to a cytoplast containing the active component(s). Ideally, an irreversible inhibitor specific for a given enzyme should be used, so that general cellular metabolism would be disturbed as little as possible. Screening studies using ethidium bromide, potassium cyanide, rotenone, and streptomycin indicated that these agents were not sufficiently irreversible to produce cell death if the agent was flushed away after a few hours' treatment. Consequently, it was decided to use the sulfhydryl reagent, iodoacetate, an inhibitor that is not specific for a given cellular component but produces a truly irreversible inactivation. In order to minimize secondary degenerative effects, the iodoacetate treatment and subsequent washes with basal medium were done at 0°-5°, so that the first time the treated cells were returned to physiologic temperatures was during the fusion procedure. A 30-min iodoacetate incubation was selected as a convenient and reproducible treatment time. Under these conditions, 10 mM iodoacetate was found to kill 100% of WI-38 cells.
Preliminary experiments using radioactively labeled whole cells indicated that untreated cells could, in fact, rescue iodoacetate-killed cells. However, no rescue was observed when cytoplasts were fused to treated cells. One explanation for this is that enough nuclear enzymes had been inactivated so that only replacing cytoplasmic enzymes would not be sufficient to rescue the cell.
In early experiments, it had been determined that a 24-hr treatment with 10 sg/ml (25 uM) of rotenone (an inhibitor of oxidative metabolism) was not lethal to WI-38 cells. Cells sublethally treated with iodoacetate would, by definition, have enough nuclear enzymes to survive. It was hypothesized that such cells would be much more sensitive to the effects of rotenone because of the iodoacetate inactivation of alternate metabolic pathways. It might then be possible to rescue these cells with cytoplasts containing the active enzymes necessary for the alternate pathways.
Cells treated sublethally with iodoacetate were, in fact, found to be much more sensitive to the effects of rotenone. However, in order for the combined treatments to produce 100% killing, the "sublethal" dose of iodoacetate produced approximately 99% killing by itself. Nonetheless, the use of rotenone permitted the concentration of iodoacetate to be decreased by more than an order of magnitude. Under these conditions, cytoplasts were able to rescue iodoacetate-treated whole cells (Fig. 1) .
The method used is as follows: Approximately 3 X 107 cells were trypsinized, pelleted for 10 min at 750 X g at 50, and resuspended in 10 ml of cold Eagle's basal medium. Enough of the iodoacetate stock solution was added to yield a final concentration of 0.3-0.9 mM, after which the cells were incubated in an ice bath for 30 min. The cells were then pelleted, the supernatant fluid was decanted, and the last few drops were removed with a pasteur pipette. After this, the cells were washed in 10 ml of cold basal medium, and resuspended in a final volume of 0. The "fusion" consisted of 0.1 ml of the treated cells and 0.1 ml of the cytoplasts mixed in a single tube. All other tubes received 0.1 ml of the appropriate cell suspension. The "mixture" consisted of cells and cytoplasts in separate tubes. Each was treated separately with Sendai virus, then washed with 2 ml of basal medium. Only after the supernatants were discarded, were the tubes combined. All aliquots were diluted 1:2 with a Sendai virus preparation (HA titer of 4000), incubated in an ice bath for 10 min, then transferred to a 370 water bath for 30 min. The cells were then planted in basal medium containing 10 pg/ml of rotenone, except for the "iodoacetate control," which was planted in rotenone-free medium. The cytoplast control defines the "background survival" of cells that failed to enucleate, and verifies that they had been rendered unable to divide by treatment with mitomycin C. The whole cell control verifies adequate killing of the whole cells by iodoacetate. The iodoacetate control shows the behavior of cells subjected to all the experimental manipulations except the final killing by rotenone. The difference in cell density and subsequent growth between the "fusion" and the "mixture" are the criteria for identifying rescue of treated cells by untreated cytoplasts.
and fused was compared to the number surviving when they were only mixed. However, treatment with Sendai virus is a relatively traumatic procedure that can kill a large percentage of previously stressed cells. Thus, the dose of iodoacetate that produces 100% killing with Sendai virus and a subsequent rotenone treatment may not produce a 100% killing if the virus step is eliminated. In order to make the controls comparable to the experimental group, the protocol described in Fig. 2 was adopted.
Under these conditions, approximately 0.2% of the cytoplasts were able to rescue whole cells. All of the aliquots described in Fig. 2 Fig. 1 shows the appearance of a typical experiment the day after planting in the microtiter dishes (3 days after fusion). The "fusion" (Fig. la) clearly has many more cells than the "mixture" (Fig. lb) . This difference in cell density represents the rescue of iodoacetate-treated cells by untreated cytoplasts. The whole cell control (Fig. ic) demonstrates the complete killing of the iodoacetate/rotenone-treated cells. If the rotenone treatment is eliminated, as in the "iodoacetate control", there is incomplete killing of the cells (Fig. id) . Even though approximately 99% of the cells have been killed, the cells appear relatively dense since the microtiter dishes have <1% of the surface area originally covered by these cells. The "cytoplast control" (Fig. le) illustrates the "background" survival of cells that failed to enucleate, but that are rendered unable to divide by mitomycin C. This represents the minimum cell density that would be expected in the "mixture" (Fig. ib) .
Once in the microtiter dishes, cell densities were scored by comparison to photographs of standard subcultivations at serial 2-fold dilutions. In 41 of 46 experiments, the "fusion" was at least twice as dense as the "mixture." The cells were fed twice weekly, and subcultivated when confluent. While in the microtiter dishes the cells were subcultivated by aspirating the trypsinized cells with a 20 gauge needle. Cells were transferred from one to two and then to four wells in the microtiter dishes and then successively to one, two, and four 16-mm wells of a multi-dish disposo-tray (Linbro Chemical Co,, Inc.). Cells in all four wells were then transferred to a 25 cm2 flask (Falcon Plastics), then to a 75 cm2 flask, and finally serial 1 :4 splits were made. WI-38 cells have a limited proliferative capacity of approximately 50 population doublings (5, 8) , and the cultures of heteroplasmons were subcultivated until this limit was reached.
The "mixture" is by far the most important control, since its failure to multiply simultaneously controls for (i) 10 (7) 12 criteria: (i) The cells in the "mixture" divided. Clearly, if the "mixture" grows, cell growth in the "fusion" cannot be interpreted to be due to rescue of iodoacetate-treated cells.
(ii) An initial cell density in the "fusion" of less than that in a standard 1:8 subcultivation. If those cells failed to grow, it could easily be secondary to density considerations rather than failure of rescue. (iii) The presence of greater than two cells on a high power search of the entire surface area of the "whole cell control." Even if the "mixture" did not grow, the potential of nonfused cells to multiply was too great to consider an experiment valid if more than a very few iodoacetate/rotenonetreated cells survived. This survival of two individual cells is to be compared to an average of approximately 3000 mitomycin C inactivated cells in both the "cytoplast control" and the "mixture," and 10,000 cells in a typical "fusion" aliquot. Fig. 3 summarizes the results of 20 experiments of 46 done that satisfied these criteria. Of the 26 failures, six were discarded because of insufficient cell density, two because the "mixture" grew even though the "whole cell" control showed good killing, one because of contamination, and 17 because of insufficient killing of the iodoacetate-treated cells. Eleven of these 17 had cell densities in the "mixture" of > 1: 8, and of these, seven (64%) grew. Six of these 17 had "mixture" cell densities of <1: 8, and of these only 1 grew. In no case did the "mixture" grow while the "fusion" did not.
The iodoacetate control (Fig. 3b) provides a baseline with which to compare the behavior of the hybrid cells. One-third of these control cultures failed to divide significantly, probably because some cultures sustained too much damage during the experimental manipulations to permit subsequent multiplication. Those that did resume logarithmic phase growth achieved 25 i 6 additional population doublings (± 1 SD). Parallel cultures, subcultivated routinely with none of the experimental trauma, achieved similar additional population doublings (29 + 3). Thus, the failure of one-third of the cultures to proliferate represents the behavior of nonhybrid cells simply exposed to the experimental manipulations. The iodoacetate controls were treated with 0.3-0.7 mM iodoacetate. The results with the heteroplasmons (Fig. 3a) at similar doses are comparable to those of the iodoacetate controls, with a 40% failure rate and 20 + 6 additional population doublings for those cells that did proliferate. Table 1 illustrates the dose-dependent tradeoff between performing experiments that meet the requirements for inclusion in the study and experiments in which the hybrids are able to resume logarithmic phase growth. The number of experiments that must be discarded because of inadequate killing of the whole cells decreases as the concentration of iodo- acetate increases. The ability of the hybrids to multiply also decreases as the dose of iodoacetate increases. This tradeoff is so balanced that the proportion of total experiments that result in growing hybrid cultures is relatively independent of the concentration of iodoacetate over the range studied.
Although the number of population doublings after fusion varies, it is clear that cytoplasts are able to rescue iodoacetatetreated cells. In the absence of a nucleus, cytoplasts cannot survive; consequently the use of iodoacetate to kill the whole cells provides a complete system for the selection of heteroplasmons. However, if this basic approach is to be used for whole cell hybridization, a second selective system is required. Although ethidium bromide proved too reversible for the experiments with cytoplasts, it was possible to use it as a partially effective second system to illustrate the general feasibility of selecting heterokaryons on the basis of complementary biochemical lesions.
Treatment of WI-38 cells with 10 jtg/ml of ethidium bromide for 24 hr at 370 produces approximately 99.9% killing. Fig. 4 shows the result of fusing cells treated in this fashion to cells treated with iodoacetate, following the general procedure described for cytoplasmic hybridization. The difference in cell density between the "mixture" (Fig. 4b) and the "fusion" (Fig. 4a) indicates that rescue has occurred. This is confirmed in Fig. 4c , depicting a "fusion" of a similar cell population that has been stained. In our experience, a culture of WI-38 cells fused with Sendai virus contains approximately 5% of cells with two or more nuclei. The fact that 80% of the cells in Fig. 4c contain two or more nuclei indicates that there has been a preferential selection for hybrid cells. The inability of ethidium bromide reliably to produce 100% killing under these conditions prevents its utilization as a totally selective system.
DISCUSSION
The purpose of this study was to develop an effective system for the selection of hybrids between cytoplasts and whole cells. Only a few common biochemicals were investigated. Once a suitable agent, iodoacetate, was found, it was used to demonstrate the feasibility of this approach, although its nonspecific action will be of limited usefulness in many experiments where biochemical interactions in newly formed hybrids are to be studied. It is valuable, however, in studies of the long-term behavior of hybrid cells, after the biochemical disturbances of the selection system have stabilized. Given the almost endless variety of enzyme inhibitors currently available, it should also be possible to tailor selection systems to the demands of a specific experiment.
It is necessary to be extremely critical in the definition of what is truly a lethal dose for inducing biochemical lesions, since a small variation in the total stress to which a cell is exposed can make a significant difference in cell survival. For example, many cell types are stressed at low population densities. Thus, the dose that just produces total killing in a "control" aliquot, where the final cell density is 0, will almost certainly be less than that necessary to produce total killing in the presence of significant numbers of viable cells. This consideration is particularly important if one wishes to use this type of selection system in conjunction with a hypoxanthine/ amethopterin/thymidine medium-type system for the hybridization of whole cells. We have fused iodoacetate-killed WI-38 cells with Lesch-Nyhan cells (cells deficient in hypoxanthine phosphoribosyltransferase) followed by cultivation in hypoxanthine/amethopterin/thymidine medium. Since it takes several weeks for these Lesch-Nyhan cells to die in this medium, the cell density was initially high in both the "mixture" and the "fusion" aliquots. In three of three experiments where "whole cell control" aliquots of the iodoacetatetreated cells showed total killing, both the "mixture" and the "fusion" grew, and karyotyping proved the growing cells to be diploid. Thus, there had, in fact, been only partial killing of the iodoacetate-treated cells in those aliquots not exposed to the additional stress of low population densities. The surviving cells then multiplied and overgrew the cultures. This difficulty was minimized in the cytoplasmic hybridization experiments by initially planting all aliquots at very low population densities, and transferring the cells to 100-fold smaller vessels only after 2 days, when all the nonfused iodoacetate-treated cells had already died.
All of the evidence implying the rescue of treated cells by cytoplasts is indirect, relying on differential survival and growth between "mixed" and "fused" populations. Because of the lack of cytoplasmic markers, we have been unable to rigorously confirm the hybrid nature of the cells that replicated. One must, therefore, recognize the possibility of artifacts in a system with undetermined variables.
Although a completely irreversible specific enzyme inhibitor is perhaps the most elegant candidate for a biochemical lesion selection system, there is a wide range of alternate approaches that may serve as well. For example, even though ethidium bromide was not sufficiently irreversible to kill cells after a short treatment, a 24-hr treatment produced enough damage to kill most of the nonhybrid cells, thus permitting its use as a partially selective agent. Any treatment that has a relatively sharp time-dependence could be used. For example, if cells could survive 4 days of treatment but not five, fusion to untreated cells after 4 days followed by an additional day or two of treatment should effectively select for the hybrid cells, since they would be the only cells receiving replacement in the form of normal cytoplasm for those substances exhausted by the prior exposure to the selective agent. Under these conditions the "agent" could potentially be any lethal stress, from metabolic poisons to vitamin or nutritional deprivations.
The use of iodoacetate provides a system that permits the selection of heteroplasmons between cytoplasts and whole cells of any cell type. Once a second such selective system becomes available, it should be possible to select for heterokaryons between any two kinds of whole cells, and this will greatly expand the range of questions that can be answered by mammalian hybridization techniques
